Oliveto Joseph's Form 4 filing
Milestone Pharmaceuticals Inc. (MIST) · filed Jan 28, 2026
- Accession no.
- 0001437782-26-000004
- Filed
- Jan 28, 2026
- Trade date
- Dec 12, 2025-Jan 26, 2026
- Filing delay
- 47 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $375.3K. It was filed 47 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Oliveto JosephCIK 0001437782 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | Common Shares | AGrant or awardAcquired | +280,000 | –F2 | – | 583,721 | Direct | |
| Dec 15, 2025 | Common Shares | SSaleDisposed | −133,054 | $2.32F4 | −$308,685.28 | 450,667 | Direct | |
| Jan 26, 2026 | Common Shares | MOption exerciseAcquired | +66,600 | –F5 | – | 517,267 | Direct | |
| Jan 26, 2026 | Common Shares | SSaleDisposed | −34,523 | $1.93F4 | −$66,629.39 | 482,744 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | Common Shares | AGrant or awardAcquired | +280,000 | $0.00 | $0 | 280,000 | Direct | |
| Jan 26, 2026 | Common Shares | MOption exerciseDisposed | −66,600 | $0.00 | $0 | 199,800 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Each PSU represents a contingent right to receive one common share.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported is a weighted average price. These shares were sold in multiple transactions. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 2 transactions in Table I.
- F5
Each RSU represents a contingent right to receive one common share.
Referenced by the price of 1 transaction in Table I.